McCall, K. and Johnston, B. (2007) Treatment options in end-of-life care: the role of palliative chemotherapy. International Journal of Palliative Nursing, 13(10), pp. 486-488. (doi: 10.12968/ijpn.2007.13.10.27491) (PMID:18073707)
Full text not currently available from Enlighten.
Abstract
Advances in medical science and technology, combined with the primary goal of medical care to restore or maintain health as far as possible, often result in the transition from active to palliative care being blurred. Treatment choices are limited in advanced disease; but paradoxically, which therapy to choose is becoming an increasingly complex decision (Weissman, 2004). The role of chemotherapy in this phase remains a controversial subject, but data are emerging to show that an increasing number of patients nearing the end of life are receiving chemotherapy (Matsuyama et al, 2006), and there is a mounting body of evidence for its use in symptom palliation (Cullen, 2003; Bowcock et al, 2004; Davis, 2005). Therefore, the traditional view that medical oncology and palliative care are two distinct disciplines may need to be modified.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Johnston, Professor Bridget |
| Authors: | McCall, K., and Johnston, B. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing > Nursing and Health Care |
| Journal Name: | International Journal of Palliative Nursing |
| Publisher: | Mark Allen Healthcare |
| ISSN: | 1357-6321 |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details